Skip to content
Welcome
  • Welcome to NJ Vaccine Science
  • Recent Blog Post
  • About NJ Vaccine Science

NJ Vaccine Science

A site dedicated to making the case for vaccine exemptions using CDC statements, vaccine inserts, and peer reviewed science.

  • Vaccine Safety
    • Adverse Events After Vaccination – How Often They Occur
    • Adverse Effects of Vaccines Evidence and Causality – 2012 IOM Report
    • Immunity for Vaccine Manufactures & HHS Failure to Submit Safety Reports
    • Plotkin Deposition
    • WHO Global Vaccine Safety Summit
    • ACIP Meeting for Hepislav-B
    • DTP: The Story of an Unsafe Vaccine
  • Cost-Benefit Analysis
    • Hep B
    • Pertussis
    • Influenza
    • NJ Assembly Woman Vandervalk – Protecting an at-risk population
  • Herd Immunity
    • Problems with Herd Immunity: District 11 Stories
      • The Medically Complicated: Keanu
      • Vaccine Injury: Gio
      • The Medically Complicated: Michael
    • Measles & Herd Immunity
  • COVID
    • The Overwhelming Evidence for Keeping Schools Open
    • How to tell the magnitude of NJ’s second wave?
    • FLU SHOT MANDATE: WILL IT HELP DURING COVID-19?
    • Alan Dershowitz and Paul Offit Advocate for Vaccine Choice
    • CDC, Oxford, Stanford Agree, COVID-19 IFR is under 0.3%

DTP: The Story of an Unsafe Vaccine

PART I: A 1991 Institute of Medicine report that investigated the DTP vaccine and associated adverse events found that:

  • insufficient evidence to indicate a causal relation between DPT vaccine and aseptic meningitis, chronic neurologic damage, erythema multiforme or other rash, Guillain-Barrè syndrome, hemolytic anemia, juvenile diabetes, learning disabilities and attention deficit disorder, peripheral mononeurop athy, or thrombocytopenia;
  • that the evidence is consistent with a causal relation between DPT vaccine and acute encephalopathy and shock and “unusual shock-like state”;
  • that the evidence indicates a causal relation between DPT vaccine and anaphylaxis, between the pertussis component of DPT vaccine and protracted, inconsolable crying, and between RA 27/3 rubella vaccine and acute arthritis;
  • that the evidence does not indicate a causal relation between DPT vaccine and infantile spasms, hypsarrythmia, Reye syndrome, or SIDS.

PART II: Although the FDA approved the first acellular DTaP vaccines for use in the United States in 1991, it took until 1996 for this less reactive vaccine to be granted approval for use in infants and children for all five of the recommended doses of pertussis, diphtheria, and tetanus vaccination. In 1997, the CDC’s Advisory Committee on Immunization Practices (ACIP) recommended the DTaP vaccine for use instead of the highly reactive whole cell DPT vaccine.

The most recent 2012 Institute of Medicine report found that for all D-T-aP containing vaccines there was inadequate evidence to accept or reject a causal relationship between 23 adverse events and the vaccine. There was evidence that convincingly supports a causal relationship for one adverse reaction (anaphylaxis) as well as evidence that favors rejection of a causal relationship for one adverse reaction (type 1 Diabetes).

Part III: In 2017 EBioMedicine published by The Lancet published a study by Peter Aaby that concluded: “DTP was associated with 5-fold higher mortality than being unvaccinated. No prospective study has shown beneficial survival effects of DTP. Unfortunately, DTP is the most widely used vaccine, and the proportion who receives DTP3 is used globally as an indicator of the performance of national vaccination programs.

It should be of concern that the effect of routine vaccinations on all-cause mortality was not tested in randomized trials. All currently available evidence suggests that DTP vaccine may kill more children from other causes than it saves from diphtheria, tetanus or pertussis. Though a vaccine protects children against the target disease it may simultaneously increase susceptibility to unrelated infections.

The recently published SAGE review called for randomized trials of DTP (Higgins et al., 2014). However, at the same time the IVIR-AC committee to which SAGE delegated the follow-up studies of the NSEs of vaccines has indicated that it will not be possible to examine the effect of DTP in an unbiased way. If that decision by IVIR-AC remains unchallenged, the present study may remain the closest we will ever come to a RCT of the NSEs of DTP.”

Follow up studies have come to the same conclusions: “Our data clearly showed that DTP vaccinations were delayed in unhealthy children. Hence, healthier children received DTP first, and DTP-unvaccinated children should, therefore, have had a higher mortality rate. Despite this, DTP was associated with increased child mortality, particularly for girls. All three studies of the introduction of DTP vaccine found negative effects which are different from what should have been expected due to the disease-preventive effects of the vaccine and the inherent biases favoring vaccinated children”

Watch Christine Stabell Benn discuss the research here:

Take Action:

1. Sign up for NJ Vaccine Science action alerts via email.

2. Stay Informed – check our our Blog and Advocacy Home page for action items, follow us on Twitter, and like us on Facebook.

3. Call and Email your Senator and Assemblymembers – ask them to oppose bill S902/A969. Use this link to find your representatives’ phone number and send them a message.

4. Call and Email the Bill Sponsors: Senate President Sweeney: [email protected] / 856-251-9801; Assemblyman Conway  [email protected] / (856) 461-3997

If you live in Legislative District 11 sign our D11 Petition to protect NJ’s RE. 

Contact NJ Vaccine Science at:

[email protected]

Sign Up for Email Action Alerts

Email Address *

First Name *

Last Name *

* indicates required


Other Useful Websites:

Hope from Holly

Vaccine Papers

National Vaccine Information Center

Informed Consent Action Network

Vaccine Injury and Compensation Program

DISCLAIMER:

All information, data and material contained, presented, or provided here is for general information purposes only and is not to be construed as reflecting the knowledge or opinions of the publisher, and is not to be construed or intended as providing medical or legal advise. The decision to vaccinate and how you implement that decision is yours and yours alone. You are encouraged to consult with your medical professional and legal adviser.

powered by XBlog Plus WordPress Theme